Clinical trial
Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has…
NCT00010231 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00010231 |
|---|---|
| Title | Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy |
| Official title | Phase I Study Of Oral, 1,25 Dihydroxycholecalciferol (Calcitriol) + Dexamethasone In Hormone-refractory Prostate Cancer |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | calcitriol, dexamethasone |
| Enrollment | 22 |
| Start date | Jun 1, 1999 |
| Primary completion | Aug 1, 2002 |
| Completion | Nov 1, 2002 |
| First posted | Jun 6, 2003 |
| Last update posted | Mar 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: